Apellis Pharmaceuticals, Inc. (APLS)
22.28
-0.52
(-2.28%)
USD |
NASDAQ |
Feb 20, 16:00
22.28
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals SG&A Expense (Quarterly) : 142.68M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 137.82M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Amicus Therapeutics, Inc. | 117.08M |
| Ionis Pharmaceuticals, Inc. | 96.81M |
| Sarepta Therapeutics, Inc. | 91.89M |